ES2095931T3 - Elementos de respuesta al acido retinoico beta, composiciones y pruebas. - Google Patents

Elementos de respuesta al acido retinoico beta, composiciones y pruebas.

Info

Publication number
ES2095931T3
ES2095931T3 ES91901044T ES91901044T ES2095931T3 ES 2095931 T3 ES2095931 T3 ES 2095931T3 ES 91901044 T ES91901044 T ES 91901044T ES 91901044 T ES91901044 T ES 91901044T ES 2095931 T3 ES2095931 T3 ES 2095931T3
Authority
ES
Spain
Prior art keywords
beta
response
elements
rethinoic
tests
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91901044T
Other languages
English (en)
Inventor
Henry Michael Sucov
Ronald Mark Evans
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Salk Institute for Biological Studies
Original Assignee
Salk Institute for Biological Studies
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Salk Institute for Biological Studies filed Critical Salk Institute for Biological Studies
Application granted granted Critical
Publication of ES2095931T3 publication Critical patent/ES2095931T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5023—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on expression patterns
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70567—Nuclear receptors, e.g. retinoic acid receptor [RAR], RXR, nuclear orphan receptors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/743—Steroid hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
    • C12N2830/002—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/60—Vector systems having a special element relevant for transcription from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
    • C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Steroid Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
  • Application Of Or Painting With Fluid Materials (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)

Abstract

LA PRESENTE INVENCION PROPORCIONA REGIONES DE CONTROL TRANSCRIPCIONALES, VECTORES DE EXPRESION QUE COMPRENDEN DICHAS REGIONES, CELULAS DE MAMIFEROS TRANSFORMADAS PARA TRANSCRIBIR Y EXPRESAR GENES DESDE DICHOS VECTORES, Y VARIOS METODOS DE ENSAYAR COMPUESTOS RESPECTO A LA ACTIVIDAD AGONISTA O ANTAGONISTA DE LAS HORMONAS, TODOS BASADOS EN EL DESCUBRIMIENTO DE ELEMENTOS DE RESPUESTA DEL RECEPTOR DE ACIDO (BETA)-RETINOICO, Y EN LA ACTIVACION DE DICHOS ELEMENTOS DE RESPUESTA EN TODAS LAS CELULAS DE MAMIFEROS SIN NECESIDAD DE TRANSFORMAR LAS CELULAS PARA EXPRESAR EL RECEPTOR INDEPENDIENTEMENTE DE SU EXPRESION ENDOGENA.
ES91901044T 1989-11-16 1990-11-13 Elementos de respuesta al acido retinoico beta, composiciones y pruebas. Expired - Lifetime ES2095931T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/438,757 US5091518A (en) 1989-11-16 1989-11-16 Beta retinoic acid response elements compositions and assays

Publications (1)

Publication Number Publication Date
ES2095931T3 true ES2095931T3 (es) 1997-03-01

Family

ID=23741886

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91901044T Expired - Lifetime ES2095931T3 (es) 1989-11-16 1990-11-13 Elementos de respuesta al acido retinoico beta, composiciones y pruebas.

Country Status (11)

Country Link
US (1) US5091518A (es)
EP (1) EP0502979B1 (es)
JP (1) JPH05504474A (es)
AT (1) ATE148166T1 (es)
AU (1) AU637871B2 (es)
CA (1) CA2072644A1 (es)
DE (1) DE69029812T2 (es)
DK (1) DK0502979T3 (es)
ES (1) ES2095931T3 (es)
GR (1) GR3022358T3 (es)
WO (1) WO1991007488A1 (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260432A (en) * 1989-06-22 1993-11-09 Sloan-Kettering Institute For Cancer Research Human gamma retinoic acid receptor DNA
US5091518A (en) * 1989-11-16 1992-02-25 The Salk Institute For Biological Studies Beta retinoic acid response elements compositions and assays
US6492137B1 (en) * 1989-11-16 2002-12-10 The Salk Institute For Biological Studies Response element compositions and assays employing same
US5861274A (en) * 1990-03-22 1999-01-19 The Salk Institute For Biological Studies Nucleic acids encoding peroxisome proliferator-activated receptor
US5369028A (en) * 1990-04-03 1994-11-29 The Salk Institute Biotechnology/Industrial Associates, Inc. DNA and mRNA encoding human neuronal nicotinic acetylcholine receptor compositions and cells transformed with same
US6440681B1 (en) 1990-04-03 2002-08-27 Merck & Co., Inc. Methods for identifying agonists and antagonists for human neuronal nicotinic acetylcholine receptors
US5401629A (en) * 1990-08-07 1995-03-28 The Salk Institute Biotechnology/Industrial Associates, Inc. Assay methods and compositions useful for measuring the transduction of an intracellular signal
WO1992006715A1 (en) * 1990-10-12 1992-04-30 Seragen, Inc. Mammalian model of a malignant disorder
AU665939B2 (en) * 1990-12-21 1996-01-25 Rockefeller University, The Liver enriched transcription factor
CA2100582A1 (en) * 1991-03-18 1992-09-19 David J. Mangelsdorf Response element compositions and assays employing same
SE500453C2 (sv) * 1991-10-07 1994-06-27 Karobio Ab Ett in vitro förfarande för utvärdering av en substans effekter
EP0552612A3 (en) * 1992-01-22 1993-10-20 Hoffmann La Roche Methods for determining and isolating compounds which bind directly to nucleosolic proteins
US5756448A (en) * 1992-02-26 1998-05-26 The General Hospital Corporation Constitute activator of retinoid (CAR) receptor polypeptides
US6989242B1 (en) 1992-02-26 2006-01-24 The General Hospital Coporation Car receptors and related molecules and methods
GB2286397B (en) 1993-03-08 1997-09-10 Salk Inst Biotech Ind Human neuronal nicotinic acetylcholine receptor compositions and methods of employing same
WO1995013299A1 (en) * 1993-11-08 1995-05-18 The Salk Institute Biotechnology/Industrial Associates, Inc. Human neuronal nicotinic acetylcholine receptor compositions and methods employing same
AU2952695A (en) * 1994-07-01 1996-01-25 Salk Institute For Biological Studies, The Mammalian peroxisome proliferator-activated receptors and uses thereof
US5702914A (en) * 1994-12-21 1997-12-30 The Salk Institute For Biological Studies Use of reporter genes for retinoid receptor screening assays having novel retinoid-associated response elements
FR2732035B1 (fr) * 1995-03-23 1997-05-30 Agronomique Inst Nat Rech Procede de regulation de l'expression d'un gene dans un baculovirus, par un site de fixation d'un recepteur de l'acide retinoique, et vecteur pour la mise en oeuvre du dit procede
US6485967B1 (en) 1995-06-07 2002-11-26 Merck & Co., Inc. Human neuronal nicotinic acetylcholine receptor α6 and β3 nucleic acid
FR2735371B1 (fr) * 1995-06-19 1997-07-18 Cird Galderma Procede pour identifier des composes antagonistes des recepteurs rars
US6489441B1 (en) 1995-09-01 2002-12-03 The Salk Institute For Biological Studies Transcriptional co-repressor that interacts with nuclear hormone receptors
AU2287397A (en) * 1996-03-14 1997-10-01 Schering Aktiengesellschaft Method of detecting the effect of test substances using hen urokinase
EP0977892A1 (en) 1997-04-24 2000-02-09 Institut National De La Sante Et De La Recherche Medicale (Inserm) Methods and compositions for use in modulating expression of matrix metalloproteinase genes
US6387673B1 (en) 1997-05-01 2002-05-14 The Salk Institute For Biological Studies Compounds useful for the modulation of processes mediated by nuclear hormone receptors, methods for the identification and use of such compounds
EP1037533A1 (en) * 1997-11-10 2000-09-27 The Salk Institute for Biological Studies Methods for the use of inhibitors of co-repressors for the treatment of neoplastic diseases
CN106480024B (zh) * 2015-08-30 2020-10-20 南通大学附属医院 受维甲酸调控的具有浓度依赖效应的重组启动子及其使用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7802587A (en) * 1986-08-01 1988-02-24 Genetics Institute Inc. High level inducible expression of heterologous genes
US5091518A (en) * 1989-11-16 1992-02-25 The Salk Institute For Biological Studies Beta retinoic acid response elements compositions and assays
ES2152920T3 (es) * 1990-02-09 2001-02-16 Salk Inst For Biological Studi Composiciones receptoras de retinoides y metodos.
AU655417B2 (en) * 1990-03-22 1994-12-22 Salk Institute For Biological Studies, The Insect retinoid receptor compositions and methods

Also Published As

Publication number Publication date
AU6956891A (en) 1991-06-13
GR3022358T3 (en) 1997-04-30
EP0502979A1 (en) 1992-09-16
DE69029812T2 (de) 1997-06-05
CA2072644A1 (en) 1991-05-17
DE69029812D1 (de) 1997-03-06
ATE148166T1 (de) 1997-02-15
WO1991007488A1 (en) 1991-05-30
EP0502979B1 (en) 1997-01-22
EP0502979A4 (en) 1993-02-10
JPH05504474A (ja) 1993-07-15
US5091518A (en) 1992-02-25
DK0502979T3 (da) 1997-04-07
AU637871B2 (en) 1993-06-10

Similar Documents

Publication Publication Date Title
GR3022358T3 (en) Beta retinoic acid response elements compositions and assays
NL189781C (nl) Fmcw-stelsel voor het meten van echo's.
FR2604256B1 (fr) Dispositif pour tester des materiaux par application d'une charge axiale
DE69328699D1 (de) Hybridisierungsassay unter Verwendung von verzweigten Nukleinsäuresonden
NL184440B (nl) Proefstrook voor het analyseren van opgeloste stoffen.
FI915150A7 (fi) Menetelmät, reagenssit ja testikäyttöpakkaukset biologisten yksiköiden alapopulaatioiden määrittämiseksi
FI944735A0 (fi) Nisäkkään melanosyyttejä stimuloivan hormonin reseptoreita ja käyttö
NL7709812A (nl) Werkwijze voor het bereiden van 6(d-(alpha)-amino-p-hy- droxyfenylacetamido) penicillanzuur.
ATE309980T1 (de) Zubereitungen zur verwendung als therapeutische und nachweismittel
DE69011329D1 (de) Pdgf-alpha-rezeptor.
DK1145002T4 (da) Bioluminescenstest for agonister eller antagonister til en calciumkoblet receptor
Kalwat et al. Gelsolin associates with the N terminus of syntaxin 4 to regulate insulin granule exocytosis
Hämäläinen et al. Expression of an α-cardiac like myosin heavy chain in diaphragm, chronically stimulated, and denervated fast-twitch muscles of rabbit
Ivell et al. Acute regulation of the bovine gene for the steroidogenic acute regulatory protein in ovarian theca and adrenocortical cells
NL7513377A (nl) Werkwijze voor de radio-immuno-analyse voor de bepaling van cardiotonisch glycoside en daartoe geschikte proefset.
NL189153C (nl) Preparaat voor het bepalen van het soortelijk gewicht van een waterig proefmonster.
IT1270612B (it) Derivati eterociclo-condensatori di morfinoidi
ATE273390T1 (de) Säugertier edg-7 rezeptor homologen
LA et al. Interleukin-1 signal transduction. Increased GTP binding and hydrolysis in membranes of a murine thymoma line (EL4).
ES2126597T5 (es) Sistema de sondas que permite efectuar la tipificacion hla dr, y procedimiento de tipificacion que utiliza dichas sondas.
FI103672B1 (fi) Menetelmä aineen vaikutusten arvioimiseksi in vitro
PL316311A1 (en) Agents for treating autoimmunisation diseases and method of treating such diseases
SU827802A1 (ru) Устройство дл испытани анкерной крепи
NL187995C (nl) Testmiddel en werkwijze voor het bepalen van ureum.
Sharpe-Timms et al. Models for the study of uterine receptivity for blastocyst implantation

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 502979

Country of ref document: ES